98%
921
2 minutes
20
Stringent response and quorum sensing (QS) are two essential mechanisms that control bacterial global metabolism for better survival. Sphingomonads are a clade of bacteria that survive successfully in diverse ecosystems. survey indicated that 36 out of 79 investigated sphingomonads strains contained more than one homolog, the gene responsible for the biosynthesis of QS signal acyl homoserine lactones (AHLs). Investigation of the regulatory effects of the stringent response gene on QS related bioactivities were carried out using mutants of UT26 and sp. SYK-6, both had three homologs. Results indicated that deletion of upregulated the overall production of AHLs and extracellular polymeric substances (EPS) in both UT26 and SYK-6 in rich medium, but affected expressions of these homologs in different ways. In the poor medium (1% LB), mutant of SYK-6 significantly lost AHLs production in broth cultivation but not in biofilm cultivation. The regulatory effects of on QS activities were growth phase dependent in UT26 and culture condition dependent in SYK-6. Our results demonstrated the negative regulatory effect of on QS activities in sphingomonads, which were very different from the positive effect found in sphingomonads containing only one circuit. This study extends the current knowledge on the intricate networks between stringent response and QS system in sphingomonads, which would help to understand their survival advantage.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11024222 | PMC |
http://dx.doi.org/10.3389/fmicb.2024.1368499 | DOI Listing |
Ann Hematol
September 2025
Excellence Center for Comprehensive Cancer (ECCCC), King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Despite therapeutic advances, multiple myeloma (MM) remains incurable, especially in relapsed/refractory (R/R) cases. B-cell maturation antigen (BCMA) is a key target for novel immunotherapies, including chimeric antigen receptor T-cell (CAR-T) therapies and bispecific T-cell engagers (BiTEs), which vary in efficacy, toxicity, and accessibility. To compare the efficacy and safety of BCMA-directed CAR-T therapies and BiTEs in R/R MM through a systematic review and meta-analysis.
View Article and Find Full Text PDFACS Nano
September 2025
School of Microelectronics, University of Science and Technology of China, Hefei, Anhui 230026, China.
Superlinear photodetectors hold significant potential in intelligent optical detection systems, such as near-field imaging. However, their current realization imposes stringent requirements on photosensitive materials, thereby limiting the flexibility of the device integration for practical applications. Herein, a tunable superlinear GaO deep-ultraviolet gate-all-around (GAA) phototransistor based on a p-n heterojunction has been proposed.
View Article and Find Full Text PDFPestic Biochem Physiol
November 2025
Department of GreenBio Science, Gyeongsang National University, Jinju 52725, Republic of Korea. Electronic address:
Bromuconazole, a widely used triazole-based pesticide, effectively controls fungal diseases in agriculture. Bromuconazole cause a potential toxic effect to non-target organisms and can have a negative impact on reproductive health in women, due to its long half-life and bioaccumulation ability. This study identifies the cytotoxicity and adverse effects of bromuconazole on trophoblastic cells (HTR-8/SVneo) and human endometrial cells (T HESCs), which are involved in implantation processes.
View Article and Find Full Text PDFJ Endocrinol Invest
September 2025
Department of Medicine-DIMED, University of Padova, Padova, Italy.
Background: Cushing's syndrome (CS) is associated with increased metabolic and cardiovascular (CV) risk factors and morbidities. Evidence-based guidelines for the management of these issues in active or remitted CS are not available, so best practice is derived from guidelines developed for the general population. We aimed to evaluate the awareness and practice variation for CV comorbidities of CS across Reference Centres (RCs) of the European Reference Network on Rare Endocrine Conditions (Endo-ERN).
View Article and Find Full Text PDFStat Methods Med Res
September 2025
Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA.
The integration of backfill cohorts into Phase I clinical trials has garnered increasing interest within the clinical community, particularly following the "Project Optimus" initiative by the U.S. Food and Drug Administration, as detailed in their final guidance of August 2024.
View Article and Find Full Text PDF